
Andrew Hirsch
@DocHirsch
Followers
289
Following
404
Media
16
Statuses
295
Pulmonologist, thrombosis doc, interests in all aspects of pulmonary vascular disease, acute and chronic PE and PH.
Montreal
Joined December 2013
RT @MarcCarrier1: Prof. @isabellemahe1 presents API-CAT at #ACC2025, published in @NEJM Extended anticoagulation with reduced-dose apixaban….
0
82
0
RT @BenzidiaI: 🚨 New study alert published in @JACCJournals CI ! 🚨. Can superficial upper extremity venous access replace femoral access in….
0
1
0
RT @PERTConsortium: March marks #DVTAwarenessMonth, reminding us to stay vigilant against deep vein thrombosis, a precursor to pulmonary em….
0
4
0
RT @camillemsimard: Join our webinar on VTE and pregnancy! Management of SVT in pregnancy and perspectives 1 year post HIGHLOW study to be….
0
17
0
RT @CNN: Donald Trump faced blowback this week from his GOP presidential rivals over his recent comments on abortion, in which he called Fl….
0
28
0
Glad to share link to our study showing #DOAC was as safe and effective as #VKA in our patient population with #CTEPH, Thanks to authors @SusanRKahn1 @BenzidiaI , Dr. D. Langleben, Dr JF Morin, Dr. A Abualsaud, Dr. C Robitaille, L. Lesenko and L. MacDonald.
0
2
14
Congratulations @VTagalakis it will be great having you as the leader of #JGH Department of Internal Medicine.
0
0
5
RT @AlbertaPHdoc: Important to have more data on the safety of #DOACs in #CTEPH. N=205. VTE rate 1.10 %/person-year on VKA and 0.32 %/perso….
0
11
0
RT @BenzidiaI: 🆕Happy to share our new article on safety and efficacy of DOAC vs VKA 💊 in CTEPH patient 🫁 : . A spe….
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
3
0
RT @TheLancetHaem: NEW: Our Profile on @SusanRKahn1, Director of the Centre of Excellence in Thrombosis and Anticoagulation Care (Montreal,….
0
5
0
Just donated to #SunYouth Montreal for #PeepsAgainstHunger in the #HCWvsHunger competition. Come on #CanadianHCW join the cause and feel good.
6
3
21
Congratulations to @SusanRKahn1 @kerstindewit for a fantastic clinical practice article in #NEJM on #PE https MUST READ for all new residents.
nejm.org
Evaluation of pulmonary embolism includes assessment of clinical probability and, if indicated, d-dimer testing. Most patients with low-risk pulmonary embolism can be treated with oral anticoagulants.
0
5
19
A great accredited tweetorial by @AlbertaPHdoc about #CTEPH an underecognized and potentially curable form of #PH.
1) Welcome to a new #accredited #tweetorial about an important complication of #pulmonaryembolism (#PE): chronic thromboembolic pulmonary hypertension #CTEPH. Follow this thread to earn 0.75h CE/#CME #physicians #physicianassociates #NPs #nurses #pharmacists.
0
1
3
RT @ManualOMedicine: Summary of Agents That Modify Blood Coagulation (Anticoagulant, Antiplatelet and Fibrinolytics). - Read More about Ant….
0
80
0
RT @NaheedD: Retweet this if you think that nurses are incredible human beings & deserve to be paid much better.
0
5K
0